Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
PharmacoEconomics
Published in: PharmacoEconomics 12/2013

01-12-2013 | Practical Application

How to Include Informal Care in Economic Evaluations

Authors: Renske J. Hoefman, Job van Exel, Werner Brouwer

Published in: PharmacoEconomics | Issue 12/2013

Login to get access

Abstract

Economic evaluations of health interventions aim to support decision making in healthcare. To effectively do so, evaluations need to include all relevant costs and effects of an intervention. Informal care provided by family or friends is an important element of care for many patients, but can have a profound impact on the health and well-being of carers. Therefore, informal care should be considered in economic evaluations of health interventions. Different methods to do so exist. This paper provides an overview of state-of-the-art methods available for this purpose, illustrated with practical examples. Since the choice of measurement and valuation technique depends on the type and perspective of the economic evaluation, this paper supports researchers in choosing the appropriate techniques to include informal care in their economic evaluation of a health intervention. We discuss the different approaches to measuring and valuing informal care, covering both partial and full valuation methods, allowing inclusion as costs or effects.
Footnotes
1
An informal carer is defined here as a person who provides care and support to a family member, friend, or acquaintance with a chronic illness, disability, or other long-lasting care need due to ill health or aging. Informal care is typically provided on a voluntary basis, arising from a prior social relationship, and without financial compensation or specific training. This definition combines several aspects from descriptions of informal care in the literature (e.g., Colombo et al. [4, Hoefman et al. 30, and Al-Janabi et al. 101], Hoefman et al. [4, 30, 101], and Al-Janabi et al. [4, 30, 101]).
 
2
These methods can also partially value informal care, depending on the valuation exercise, e.g., when a willingness-to-pay question specifically excludes health or labor participation effects, the valuation is clearly partial when such effects do occur.
 
3
Values are in 2012 euros. Values in euros before 2012 can be converted to 2012 euros by multiplying with the annual average rates of change in harmonized indices of consumer prices (HICPs) [102]. Currencies other than euros were first converted with historical currency rates.
 
4
In these experiments, only the number of hours per week change; all other things, such as the recipient’s need for care, are assumed to remain equal in order to avoid contamination of values with other aspects (such as the health of the patient).
 
Literature
1.
Brazier J, Ratcliffe J, Salomon JA, Tsuchiya A. Measuring and valuing health benefits for economic evaluation. Oxford: Oxford University Press; 2007.
2.
Brouselle A, Lessard C. Economic evaluation to inform health care decision-making: promise, pitfalls and a proposal for an alternative path. Soc Sci Med. 2011;72(6):832–9.CrossRef
3.
Stolk EA, de Bont A, van Halteren AR, Bijlmer RJ, Poley MJ. Role of health technology assessment in shaping the benefits package in The Netherlands. Expert Rev Pharmacoecon Outcomes Res. 2009;9(1):85–94.PubMedCrossRef
4.
Colombo F, Llena-Nozal A, Mercier J, Tjadens F. Help wanted? Providing and paying for long-term care. Paris: OECD Publishing; 2011.
5.
6.
Clark AM, Reid ME, Morrison CE, Capewell S, Murdoch DL, McMurray JJ. The complex nature of informal care in home-based heart failure management. J Adv Nursing. 2008;61(4):373–83.CrossRef
7.
Knowlton AR, Arnsten JH, Gourevitch MN, Eldred L, Wilkinson JD, Rose CD, et al. Microsocial environmental influences on highly active antiretroviral therapy outcomes among active injection drug users: The role of informal caregiving and household factors. JAIDS. 2007;46:S110–9.PubMed
8.
Jiménez-Martín S, Prieto CV. The trade-off between formal and informal care in Spain. Eur J Health Econ. 2012;13(4):461–90.PubMedCrossRef
9.
Clark RE, Xie H, Adachi-Mejia AM, Sengupta A. Substitution between formal and informal care for persons with severe mental illness and substance use disorders. J Ment Health Policy Econ. 2001;4(3):123–132.
10.
Weaver FM, Weaver BA. Does availability of informal care within the household impact hospitalisation? Health Econ Policy Law. Epub 2013 Apr 8:1–23.
11.
Brouwer WB, Van Exel NJ, Van den Berg B, Van den Bos GA, Koopmanschap MA. Process utility from providing informal care: the benefit of caring. Health Policy. 2005;74(1):85–99.PubMedCrossRef
12.
Schulz R, Beach SR. Caregiving as a risk factor for mortality: the Caregiver Health Effects Study. JAMA. 1999;282(23):2215–9.PubMedCrossRef
13.
Wilson MR, Van Houtven CH, Stearns SC, Clipp EC. Depression and missed work among informal caregivers of older individuals with dementia. J Family Econ Issues. 2007;28(4):684–98.CrossRef
14.
Joling KJ, van Hout HPJ, Schellevis FG, van der Horst HE, Scheltens P, Knol DL, et al. Incidence of depression and anxiety in the spouses of patients with dementia: a naturalistic cohort study of recorded morbidity with a 6-year follow-up. Am J Geriatr Psychiatry. 2010;18(2):146.PubMedCrossRef
15.
Van Vliet D, De Vugt ME, Bakker C, Koopmans RTCM, Verhey FRJ. Impact of early onset dementia on caregivers: a review. Int J Geriatr Psychiatry. 2010;25(11):1091–100.PubMedCrossRef
16.
Bobinac A, van Exel N, Rutten FFH, Brouwer WBF. Health effects in significant others. Med Decis Making. 2011;31(2):292.PubMedCrossRef
17.
Tolkacheva N, Van Groenou MB, De Boer A, Van Tilburg T. The impact of informal care-giving networks on adult children’s care-giver burden. Ageing Soc. 2011;31(1):34.PubMedCrossRef
18.
Gold MR, Siegel JE, Russell LB, Weinstein M. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
19.
Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 2005.
20.
Jacobs P, Ohinmaa A, Brady B. Providing systematic guidance in pharmacoeconomic guidelines for analysing costs. Pharmacoeconomics. 2005;23(2):143–53.PubMedCrossRef
21.
Health Care Insurance Board. Guidelines for pharmaco-economic research; evaluation and actualisation [Richtlijnen voor farmaco-economisch onderzoek; evaluatie en actualisatie]; 2005.
22.
Van Exel J, Bobinac A, Koopmanschap M, Brouwer W. The invisible hands made visible: recognizing the value of informal care in healthcare decision-making. Expert Rev Pharmacoecon Outcomes Res. 2008;8(6):557–61.PubMedCrossRef
23.
National Institute for Clinical Excellence. Guide to the methods of technology appraisal; 2008.
24.
Bobinac A, Van Exel NJ, Rutten FF, Brouwer WB. Caring for and caring about: disentangling the caregiver effect and the family effect. J Health Econ. 2010;29(4):549–56.PubMedCrossRef
25.
26.
Stone PW, Chapman RH, Sandberg EA, Liljas B, Neumann PJ. Measuring costs in cost–utility analyses. Variations in the literature. Int J Technol Assess Health Care. 2000;16(1):111–24.PubMedCrossRef
27.
Van den Berg B, Brouwer WB, Koopmanschap MA. Economic valuation of informal care. An overview of methods and applications. Eur J Health Econ. 2004;5(1):36–45.PubMedCrossRef
28.
Koopmanschap MA, Van Exel JN, Van den Berg B, Brouwer WB. An overview of methods and applications to value informal care in economic evaluations of healthcare. Pharmacoeconomics. 2008;26(4):269–80.PubMedCrossRef
29.
Deeken JF, Taylor KL, Mangan P, Yabroff KR, Ingham JM. Care for the caregivers: a review of self-report instruments developed to measure the burden, needs, and quality of life of informal caregivers. J Pain Symptom Manage. 2003;26(4):922–53.PubMedCrossRef
30.
Hoefman RJ, Van Exel NJA, Brouwer WBF. iVICQ. iMTA Valuation of Informal Care Questionnaire, Version 1.1; 2011.
31.
Krol M, Papenburg J, Koopmanschap M, Brouwer W. Do productivity costs matter? The impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders. Pharmacoeconomics. 2011;29(7):601–19.PubMed
32.
Brouwer WBF, Van Exel NJA, Koopmanschap MA, Rutten FFH. The valuation of informal care in economic appraisal. Int J Technol Assess Health Care. 1999;15(1):147–60.PubMedCrossRef
33.
Goodrich K, Kaambwa B, Al-Janabi H. The inclusion of informal care in applied economic evaluation: a review. Value Health. 2012;15(6):975–81.PubMedCrossRef
34.
Van den Berg B, Spauwen P. Measurement of informal care: an empirical study into the valid measurement of time spent on informal caregiving. Health Econ. 2006;15(5):447–60.PubMedCrossRef
35.
Wimo A, Gustavsson A, Jönsson L, Winblad B, Hsu M, Gannon B. Application of resource utilization in dementia (RUD) instrument in a global setting. Alzheimers Dement. 2012;9:429–35.e17.
36.
Hoefman RJ, van Exel NJA, Foets M, Brouwer WBF. Sustained informal care: the feasibility, construct validity and test–retest reliability of the CarerQol-instrument to measure the impact of informal care in long-term care. Aging Mental Health. 2011;15(8):1018–27.PubMedCrossRef
37.
Van Exel NJA, Van den Berg B, Koopmanschap MA, van den Bos GAM, Brouwer WBF. Informal care in the Netherlands: a situational sketch of informal care-providers reached via Informal Care Centres. Institute of Medical Technology Assessment Report 02.58b. Rotterdam: Erasmus MC, 2002.
38.
Van Exel NJ, Koopmanschap MA, Van den Berg B, Brouwer WB, Van den Bos GA. Burden of informal caregiving for stroke patients. Identification of caregivers at risk of adverse health effects. Cerebrovasc Dis. 2005;19(1):11–7.
39.
Van den Berg B, Brouwer W, Van Exel J, Koopmanschap M. Economic valuation of informal care: the contingent valuation method applied to informal caregiving. Health Econ. 2005;14(2):169–83.PubMedCrossRef
40.
Brouwer WB, Van Exel NJ, Van Gorp B, Redekop WK. The CarerQol instrument: a new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations. Qual Life Res. 2006;15(6):1005–21.PubMedCrossRef
41.
Brouwer WB, Van Exel NJ, Van de Berg B, Dinant HJ, Koopmanschap MA, Van den Bos GA. Burden of caregiving: evidence of objective burden, subjective burden, and quality of life impacts on informal caregivers of patients with rheumatoid arthritis. Arthritis Rheum. 2004;51(4):570–7.PubMedCrossRef
42.
Van Exel NJ, Brouwer WB, Van den Berg B, Koopmanschap MA, Van den Bos GA. What really matters: an inquiry into the relative importance of dimensions of informal caregiver burden. Clin Rehabil. 2004;18(6):683–93.PubMedCrossRef
43.
Van Exel J, de Graaf G, Brouwer W. Give me a break! Informal caregiver attitudes towards respite care. Health Policy. 2008;88(1):73–87.PubMedCrossRef
44.
Wimo A, Reed CC, Dodel R, Belger M, Jones RW, Happich M, et al. The GERAS study: a prospective observational study of costs and resource use in community dwellers with Alzheimer’s disease in three European countries–study design and baseline findings. J Alzheimers Dis. 2013;36:385–99.PubMed
45.
Gustavsson A, Jonsson L, Rapp T, Reynish E, Ousset P, Andrieu S, et al. Differences in resource use and costs of dementia care between European countries: baseline data from the ICTUS study. J Nutr Health Aging. 2010;14(8):648–54.PubMedCrossRef
46.
Brouwer WBF, Van Exel NJA, Tilford MJ. Incorporating caregiver and family effects in economic evaluations of child health. In: Ungar WJ, editor. Economic evaluation in child health. Oxford: Oxford University Press; 2010.
47.
Van Exel NJ, Scholte op Reimer WJ, Brouwer WB, Van den Berg B, Koopmanschap MA, Van den Bos GA. Instruments for assessing the burden of informal caregiving for stroke patients in clinical practice: a comparison of CSI, CRA, SCQ and self-rated burden. Clin Rehabil. 2004;18(2):203–14.PubMedCrossRef
48.
49.
Al-Janabi H, Frew E, Brouwer W, Rappange D, Van Exel J. The inclusion of positive aspects of caring in the Caregiver Strain Index: tests of feasibility and validity. Int J Nursing Studies. 2010;47(8):984–93.CrossRef
50.
Payakachat N, Tilford JM, Brouwer WBF, van Exel NJ, Grosse SD. Measuring health and well-being effects in family caregivers of children with craniofacial malformations. Qual Life Res. 2011;20(9):1485–95.
51.
Poley MJ, Brouwer WB, Van Exel NJ, Tibboel D. Assessing health-related quality-of-life changes in informal caregivers: an evaluation in parents of children with major congenital anomalies. Qual Life Res. 2012;21(5):849–61.PubMedCrossRef
52.
Veenhoven R. Conditions of happiness. Dordrecht: Kluwer Academic; 1984.
53.
Francis J, McDaid D. SCIE’s work on economics and the importance of informal care. In: Cutis L, editor. Unit costs of health and social care 2009. Canterbury: University of Kent; 2009. p. 27–33.
54.
Faria R, Weatherly H, van den Berg B. A review of approaches to measure and monetarily value informal care. In: Curtis L, editor. Unit Costs of Health and Social Care 2012. Kent: PSSRU; 2012. p. 22–31.
55.
Al-Janabi H, Flynn TN, Coast J. Estimation of a preference-based carer experience scale. Med Decis Making. 2011;3:458–68.CrossRef
56.
Hoefman RJ, Van Exel NJA, Redekop WK, Looren-de Jong S, Brouwer WBF. A new test of the validity of the CarerQol instrument: measuring ‘care-related quality of life’ of informal caregivers for use in economic evaluations. Qual Life Res. 2011;20(6):875–87.PubMedCrossRef
57.
Hoefman RJ, Van Exel NJA, Rose JM, Lawerman-van de Wetering EJ, Brouwer WBF. A discrete choice experiment to obtain a tariff for valuing informal care situations measured with the CarerQol instrument. Med Decis Making. Epub 2013 Jun 14.
58.
Ferrer-i-Carbonell A, Frijters P. How important is methodology for the estimates of the determinants of happiness? Econ J. 2004;114:641–59.CrossRef
59.
Frey BS, Stutzer A. What can economists learn from happiness research? J Econ Lit. 2002;40:402–35.CrossRef
60.
Van den Berg B, Brouwer W, Van Exel J, Koopmanschap M, Van den Bos GA, Rutten F. Economic valuation of informal care: lessons from the application of the opportunity costs and proxy good methods. Soc Sci Med. 2006;62(4):835–45.PubMedCrossRef
61.
62.
Patel A, Knapp M, Evans A, Perez I, Kalra L. Training care givers of stroke patients: economic evaluation. BMJ. 2004;328(7448):1102.PubMedCrossRef
63.
Leal J, Luengo-Fernández R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J. 2006;27(13):1610–9.PubMedCrossRef
64.
McCrone P, Darbishire L, Ridsdale L, Seed P. The economic cost of chronic fatigue and chronic fatigue syndrome in UK primary care. Psychol Med. 2003;33(2):253–61.PubMedCrossRef
65.
Kobelt G, Berg J, Lindgren P, Fredrikson S, Jönsson B. Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2006;77(8):918–26.PubMedCrossRef
66.
Romeo R, Knapp M, Scott S. Economic cost of severe antisocial behaviour in children–and who pays it. Br J Psychiatry. 2006;188(6):547–53.PubMedCrossRef
67.
Mihalopoulos C, Cadilhac DA, Moodie ML, Dewey HM, Thrift AG, Donnan GA, et al. Development and application of Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS): An Australian economic model for stroke. Int J Technol Assess Health Care. 2005;21(4):499–505.PubMed
68.
Thalanany MM, Mugford M, Mitchell-Inwang C. Visiting adult patients in intensive care: the importance of relatives’ travel and time costs. Intensive Crit Care Nursing. 2006;22(1):40–8.CrossRef
69.
Dewey HM, Thrift A, Mihalopoulos C, Carter R, Macdonell R, McNeil J, et al. Informal care for stroke survivors results from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke. 2002;33(4):1028–33.PubMedCrossRef
70.
Smith CA, Frick KD. Cost–utility analysis of high-vs. low-intensity home-and community-based service interventions. Soc Work Public Health. 2008;23(6):75–98.PubMedCrossRef
71.
Wilson E, Thalanany M, Shepstone L, Charlesworth G, Poland F, Harvey I, et al. Befriending carers of people with dementia: a cost utility analysis. Int J Geriatr psychiatry. 2009;24(6):610–23.PubMedCrossRef
72.
Agha Z, Lofgren RP, VanRuiswyk JV. Is antibiotic prophylaxis for bacterial endocarditis cost-effective? Med Decis Making. 2005;25(3):308–20.PubMedCrossRef
73.
Andersson F, Kjellman M, Forsberg G, Möller C, Arheden L. Comparison of the cost-effectiveness of budesonide and sodium cromoglycate in the management of childhood asthma in everyday clinical practice. Ann Allergy Asthma Immunol. 2001;86(5):537–44.PubMedCrossRef
74.
Duff P, Dolphin C. Cost-benefit analysis of assistive technology to support independence for people with dementia—Part 2: results from employing the ENABLE cost–benefit model in practice. Technol Disability. 2007;19(2):79–90.
75.
Getsios D, Blume S, Ishak KJ, Maclaine GD. Cost effectiveness of donepezil in the treatment of mild to moderate Alzheimer’s disease. Pharmacoeconomics. 2010;28(5):411–27.PubMedCrossRef
76.
Graff MJ, Adang EM, Vernooij-Dassen MJ, Dekker J, Jönsson L, Thijssen M, et al. Community occupational therapy for older patients with dementia and their care givers: cost effectiveness study. BMJ. 2008;336(7636):134–8.PubMedCrossRef
77.
Schneider J, Hallam A, Islam MK, Murray J, Foley B, Atkins L, et al. Formal and informal care for people with dementia: variations in costs over time. Ageing Soc. 2003;23(3):303–26.CrossRef
78.
Hollander J, Liu G, Chappell N. Who cares and how much. Healthcare Q. 2009;12(2):42–9.CrossRef
79.
Gaugler JE, Zarit SH, Townsend A, Parris Stephens M, Greene R. Evaluating community-based programs for dementia caregivers: the cost implications of adult day services. J Appl Gerontol. 2003;22(1):118–33.CrossRef
80.
Gitlin LN, Hodgson N, Jutkowitz E, Pizzi L. The cost-effectiveness of a nonpharmacologic intervention for individuals with dementia and family caregivers: the tailored activity program. Am J Geriatr Psychiatry. 2010;18(6):510.PubMedCrossRef
81.
Nichols LO, Chang C, Lummus A, Burns R, Martindale-Adams J, Graney MJ, et al. The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer’s disease. J Am Geriatr Soc. 2007;56(3):413–20.PubMedCrossRef
82.
van Helvoort-Postulart D, Dirksen CD, Nelemans PJ, Kroon AA, Kessels AG, de Leeuw PW, et al. Renal artery stenosis: cost-effectiveness of diagnosis and treatment. Radiology. 2007;244(2):505–13.PubMedCrossRef
83.
Hakkaart-van Roijen L, Tan SS, Bouwmans CAM. Handleiding voor kostenonderzoek, methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. Geactualiseerde versie; 2010.
84.
Van den Berg B, Ferrer-i-Carbonell A. Monetary valuation of informal care: the well-being valuation method. Health Econ. 2007;16(11):1227–44.PubMedCrossRef
85.
Bromley DW. Property rights and natural resource damage assessments. Ecol Econ. 1995;14(2):129–35.CrossRef
86.
Van Exel NJA, Brouwer WBF, Van den Berg B, Koopmanschap MA. With a little help from an anchor: discussion and evidence of anchoring effects in contingent valuation. J Socio Econ. 2006;35(5):836–53.CrossRef
87.
Arrow K, Solow R. Report of the NOAA panel on contingent valuation; 1993.
88.
Louviere J, Flynn T, Carson R. Discrete choice experiments are not conjoint analysis. J Choice Model. 2010;3(3):57–72.CrossRef
89.
Van den Berg B, Bleichrodt H, Eeckhoudt L. The economic value of informal care: a study of informal caregivers’ and patients’ willingness to pay and willingness to accept for informal care. Health Econ. 2005;14(4):363–76.PubMedCrossRef
90.
De Meijer C, Brouwer W, Koopmanschap M, Van den Berg B, Van Exel J. The value of informal care—a further investigation of the feasibility of contingent valuation in informal caregivers. Health Econ. 2010;19(7):755–71.PubMedCrossRef
91.
Van den Berg B, Al M, Brouwer W, Van Exel J, Koopmanschap M. Economic valuation of informal care: the conjoint measurement method applied to informal caregiving. Soc Sci Med. 2005;61(6):1342–55.
92.
Van den Berg B, Al M, Van Exel J, Koopmanschap M, Brouwer W. Economic valuation of informal care: conjoint analysis applied in a heterogeneous population of informal caregivers. Value Health. 2008;11(7):1041–50.PubMedCrossRef
93.
Mentzakis E, Ryan M, McNamee P. Using discrete choice experiments to value informal care tasks: exploring preference heterogeneity. Health Econ. 2011;20:331–47.PubMedCrossRef
94.
De Groot AWM, Van Praag BMS, Velthuijsen JW, Zijderveld CE. Wie dan zorgt… De zorgtijd voor kinderen en ouderen onderzocht:zelf zorgen of hulp inhuren? In: Hazeu CA, Eggelte JJA, den Butter FAG, editors. Naar een vrijwel volledige arbeidsparticipatie. The Hague: WRR; 2000.
95.
Gustavsson A, Jonsson L, McShane R, Boada M, Wimo A, Zbrozek AS. Willingness-to-pay for reductions in care need: estimating the value of informal care in Alzheimer’s disease. Int J Geriatr Psychiatry. 2010;25(6):622–32.PubMed
96.
EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.CrossRef
97.
Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–92.PubMedCrossRef
98.
99.
Lamers LM, McDonnell J, Stalmeier PF, Krabbe PF, Busschbach JJ. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 2006;15(10):1121–32.PubMedCrossRef
100.
Al-Janabi H, Coast J, Flynn TN. What do people value when they provide unpaid care for an older person? A meta-ethnography with interview follow-up. Soc Sci Med. 2008;67(1):111–21.PubMedCrossRef
101.
Saltman RB, Dubois HF, Chawla M. The impact of aging on long-term care in Europe and some potential policy responses. Int J Health Services. 2006;36(4):719–46.CrossRef
102.
Metadata
Title
How to Include Informal Care in Economic Evaluations
Authors
Renske J. Hoefman
Job van Exel
Werner Brouwer
Publication date
01-12-2013
Publisher
Springer International Publishing
Published in
PharmacoEconomics / Issue 12/2013
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI
https://doi.org/10.1007/s40273-013-0104-z

Other articles of this Issue 12/2013

PharmacoEconomics 12/2013 Go to the issue

Current Opinion

Assessing the Cost Effectiveness of Pre-Exposure Prophylaxis for HIV Prevention in the US

Commentary

Search MEDLINE for Economic Evaluations: Tips to Translate an OVID Strategy into a PubMed One

Original Research Article

A Closer Look at Decision and Analyst Error by Including Nonlinearities in Discrete Choice Models: Implications on Willingness-to-Pay Estimates Derived from Discrete Choice Data in Healthcare

Systematic Review

The Estimation of Utility Weights in Cost-Utility Analysis for Mental Disorders: A Systematic Review

Acknowledgement to Referees

Acknowledgments

Systematic Review

Cost Effectiveness of Medication Adherence-Enhancing Interventions: A Systematic Review of Trial-Based Economic Evaluations